Theravance Biopharma, Inc.
TBPH
$17.06
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.42% | 201.61% | 256.94% | 260.85% | 252.63% |
| Total Receivables | -7.02% | 1.50% | 39.60% | 8.44% | 53.29% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.80% | 82.05% | 76.85% | -18.42% | -37.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.75% | 177.93% | 159.80% | 204.51% | 207.02% |
|
|
|||||
| Total Current Assets | 13.75% | 177.93% | 159.80% | 204.51% | 207.02% |
| Net Property, Plant & Equipment | -18.23% | -17.17% | -15.39% | -14.59% | -17.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.23% | -83.55% | -83.65% | -87.15% | -86.88% |
| Total Assets | 10.27% | 37.47% | 37.10% | 16.67% | 17.68% |
|
|
|||||
| Total Accounts Payable | -61.07% | -54.32% | 14.54% | 52.20% | 0.06% |
| Total Accrued Expenses | 25.73% | 17.71% | 46.87% | 78.89% | 45.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.93% | -0.51% | 2.18% | 160.10% | 158.26% |
| Total Finance Division Other Current Liabilities | -- | -9.67% | -9.67% | -37.23% | 311.34% |
| Total Other Current Liabilities | -- | -9.67% | -9.67% | -37.23% | 311.34% |
| Total Current Liabilities | -43.69% | 0.87% | 19.38% | 59.62% | 138.09% |
|
|
|||||
| Total Current Liabilities | -43.69% | 0.87% | 19.38% | 59.62% | 138.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.90% | -20.34% | -18.79% | -17.42% | -16.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.49% | 10.52% | 10.58% | 5.14% | 7.81% |
| Total Liabilities | -10.50% | 2.32% | 5.73% | 7.23% | 19.51% |
|
|
|||||
| Common Stock & APIC | 0.97% | 0.88% | 1.33% | 1.56% | 1.60% |
| Retained Earnings | 5.82% | 11.70% | 10.97% | 3.09% | 1.39% |
| Treasury Stock & Other | -660.00% | -- | 771.43% | -36.00% | 54.55% |
| Total Common Equity | 28.84% | 75.07% | 69.03% | 25.33% | 16.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.84% | 75.07% | 69.03% | 25.33% | 16.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.84% | 75.07% | 69.03% | 25.33% | 16.09% |
|
|
|||||